Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Methylene Blue in Healthy Aging, Mild Cognitive Impairment and Alzheimer's Disease (MB2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02380573
Recruitment Status : Suspended (Pending enrollment of new subjects if new funding obtained)
First Posted : March 5, 2015
Last Update Posted : May 11, 2020
Sponsor:
Collaborator:
Texas Alzheimer's Research and Care Consortium (TARCC)
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : July 2022
Estimated Study Completion Date : July 2023
Publications: